Biotech grants
Explore grants for biotech companies. This directory brings together funding for therapeutics, diagnostics, platform technologies, bioprocessing and translational research, from health research agencies, national innovation programs, disease foundations and industry partnerships.
Showing 385-408 of 2,745 grants
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research
🇺🇸NIH · United States
Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification
🇺🇸NIH · United States
Funds identifying and validating a disease target, then finding a preliminary drug, biologic or combination-product lead against it.
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype
🇺🇸NIH · United States
Funds turning a preliminary drug, biologic or combination-product lead into a combination-product prototype for heart, lung, blood or sleep disease.
A+ Early-Stage Startup Grant Program
🇹🇼ITRI · Taiwan
Funds Taiwan early-stage technology startups moving from functional prototype to MVP validation and market landing.
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement
🇺🇸NIH · United States
Funds the continuation of a dental clinical trial the institute already supports, or a competing revision that changes what it does.
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement
🇺🇸NIH · United States
Funds the planning of a clinical trial in oral, dental or craniofacial health, and then running it, as one phased award.
Stimulating Hematology Investigation: New Endeavors (SHINE)
🇺🇸NIH · United States
Funds basic and early translational research on non-cancerous blood disorders, in topics three institutes refresh every year.
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
NIH · United States
Funds academic-industry partnerships that turn a lab discovery into a working diagnostic or treatment tool, without a clinical trial attached.
Basic Research in Cancer Health Disparities (R01)
NIH · United States
Funds basic mechanistic research into the biological and genetic causes of cancer health disparities — and into building the tools that research needs.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
NIH · United States
Funds mechanistic work on the lasting harms cancer therapy causes, and on turning that understanding into ways to prevent them.
Development of Animal Models and Related Biological Materials for Research
🇺🇸NIH · United States
Funds developing or improving animal models and related materials — but only where they serve several institutes and several body systems.
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders
🇺🇸NIH · United States
Funds the discovery and first evaluation of biomarkers for neurological and neuromuscular disorders, ending with candidates ready for formal validation.
Exploratory/Developmental Bioengineering Research Grants (EBRG)
NIH · United States
Funds early feasibility work on a new biomedical tool, instrument or method that could improve research, care delivery or accessibility.
Focused Technology Research and Development
🇺🇸NIH · United States
Funds a project that develops a biomedical research technology and only that — no biological question attached.
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy
🇺🇸NIH · United States
Funds work combining imaging with liquid biopsy during cancer treatment, to see sooner whether it is working or resistance is emerging.
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin
🇺🇸NIH · United States
Funds basic research on skin injury from chemicals identified as public health threats, looking for shared pathways a single countermeasure could target.
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01)
🇺🇸NIH · United States
Funds mechanistic work on how bariatric surgery changes a person's cancer risk — not on weight loss or diabetes.
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21)
🇺🇸NIH · United States
Funds proof-of-concept work on how bariatric surgery changes cancer risk — and refuses applications that already have unpublished preliminary data.
Molecular Imaging of Inflammation in Cancer
🇺🇸NIH · United States
Funds molecular imaging that shows how inflammation and cancer interact inside a living body, rather than in a dish or a slide.
Mood and Psychosis Symptoms during the Menopause Transition (R01)
NIH · United States
Funds translational work on the neurobiology behind mood and psychotic symptoms during the menopause transition, aimed at treatment targets.
Mood and Psychosis Symptoms during the Menopause Transition (R21)
NIH · United States
Funds the exploratory version of the same translational work on mood and psychotic symptoms during the menopause transition.
Natural History of Disorders Screenable in the Newborn Period
NIH · United States
Funds studies of how conditions found by newborn screening unfold — the sequence and timing of symptoms, and what changes the course.
NIH Exploratory/Developmental Research Project Grant
NIH · United States
Funds an early-stage, high-risk project that includes a clinical trial — and at some institutes only a mechanistic one counts.
NIH Research Project Grant
NIH · United States
Funds a defined research project in the investigator's own area of expertise, through the announcement most NIH institutes keep permanently open.